Literature DB >> 36042062

The difference in the diaphragmatic physiological measures between inspiratory and expiratory phases in ALS.

Ryo Morishima1,2, Toshio Shimizu3, Yukie Ishizaka4, Hideki Kimura3, Kota Bokuda3, Kazushi Takahashi3, Masanari Itokawa5,6.   

Abstract

INTRODUCTION: We aimed to clarify the differences in static and dynamic diaphragm parameters between the expiratory and inspiratory phases in amyotrophic lateral sclerosis (ALS).
METHODS: Twenty patients with early-stage ALS and 16 healthy controls were enrolled in the study. We measured the amplitudes of compound muscle action potential (phCMAP) by electrical stimulation of the phrenic nerve and the zone of apposition wall thickness of the diaphragm (DT) using ultrasonography. We analyzed the differences in phCMAP (∆phCMAP) and DT (∆DT) between the end-inspiratory and end-expiratory phases and their correlation with forced vital capacity (FVC).
RESULTS: The ΔphCMAP (mean 129.7 ± SD 204.7 µV) and ∆DT (0.80 ± 0.88 cm) in patients were significantly smaller than those in controls (348.6 ± 247.7 µV, p = 0.0003 and 1.89 ± 1.10 cm, p = 0.0002, respectively). Although ∆DT was significantly correlated with FVC, we found no correlation between ∆phCMAP and FVC. The phCMAP was paradoxically smaller during inspiration than during expiration in 35% of patients but in none of the controls.
CONCLUSION: Dynamic parameters of the diaphragm were abnormal in early-stage ALS. The paradoxical reduction in phCMAP during inspiration may reflect early respiratory dysfunction. Assessment of dynamic abnormalities of the diaphragm may provide helpful information for respiratory management in patients with ALS.
© 2022. Fondazione Società Italiana di Neurologia.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Diaphragm ultrasonography; Phrenic nerve conduction study; Respiratory dysfunction

Year:  2022        PMID: 36042062     DOI: 10.1007/s10072-022-06371-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.830


  35 in total

1.  EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives.

Authors:  P M Andersen; G D Borasio; R Dengler; O Hardiman; K Kollewe; P N Leigh; P-F Pradat; V Silani; B Tomik
Journal:  Eur J Neurol       Date:  2005-12       Impact factor: 6.089

2.  Respiratory measures in amyotrophic lateral sclerosis.

Authors:  Noah Lechtzin; Merit E Cudkowicz; Mamede de Carvalho; Angela Genge; Orla Hardiman; Hiroshi Mitsumoto; Jesus S Mora; Jeremy Shefner; Leonard H Van den Berg; Jinsy A Andrews
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2018-03-23       Impact factor: 4.092

3.  Phrenic nerve studies predict survival in amyotrophic lateral sclerosis.

Authors:  Susana Pinto; Anabela Pinto; Mamede de Carvalho
Journal:  Clin Neurophysiol       Date:  2012-07-03       Impact factor: 3.708

Review 4.  Neuromuscular ultrasound for evaluation of the diaphragm.

Authors:  Aarti Sarwal; Francis O Walker; Michael S Cartwright
Journal:  Muscle Nerve       Date:  2013-02-04       Impact factor: 3.217

5.  Phrenic nerve conduction in amyotrophic lateral sclerosis.

Authors:  T Evangelista; M Carvalho; A Pinto; M de L Luís
Journal:  J Neurol Sci       Date:  1995-05       Impact factor: 3.181

6.  Changes of the phrenic nerve motor response in amyotrophic lateral sclerosis: longitudinal study.

Authors:  Susana Pinto; Ruth Geraldes; Nuno Vaz; Anabela Pinto; Mamede de Carvalho
Journal:  Clin Neurophysiol       Date:  2009-10-14       Impact factor: 3.708

Review 7.  AAEM minimonograph #40: clinical neurophysiology of the respiratory system.

Authors:  C F Bolton
Journal:  Muscle Nerve       Date:  1993-08       Impact factor: 3.217

8.  Predicting respiratory insufficiency in amyotrophic lateral sclerosis: the role of phrenic nerve studies.

Authors:  Susana Pinto; Antónia Turkman; Anabela Pinto; Michael Swash; Mamede de Carvalho
Journal:  Clin Neurophysiol       Date:  2009-04-01       Impact factor: 3.708

9.  Cough peak flow decline rate predicts survival in patients with amyotrophic lateral sclerosis.

Authors:  Chiharu Matsuda; Toshio Shimizu; Yuki Nakayama; Michiko Haraguchi
Journal:  Muscle Nerve       Date:  2018-12-04       Impact factor: 3.217

Review 10.  Diaphragmatic Neurophysiology and Respiratory Markers in ALS.

Authors:  Mamede de Carvalho; Michael Swash; Susana Pinto
Journal:  Front Neurol       Date:  2019-02-21       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.